ChoA Pharmaceutical Co., LTD. (KOSDAQ: 034940)

South Korea flag South Korea · Delayed Price · Currency is KRW
955.00
-48.00 (-4.79%)
Dec 19, 2024, 9:00 AM KST
-52.25%
Market Cap 31.38B
Revenue (ttm) 61.46B
Net Income (ttm) -13.07B
Shares Out 30.98M
EPS (ttm) -422.06
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 356,367
Open 1,001.00
Previous Close 1,003.00
Day's Range 943.00 - 1,001.00
52-Week Range 797.00 - 2,020.00
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Mar 14, 2025

About ChoA Pharmaceutical Co., LTD.

ChoA Pharmaceutical Co., Ltd. operates as a pharmaceutical company in South Korea. The company produces approximately 200 medicines and health foods, including 30 internal ampoule products, such as Hepos, Fematin, Vasoclean, Mabis, etc. Its products include drugs for digestive, circulatory, and respiratory systems; vitamins, minerals, and nutrients; anti inflammation and analgesics; peripheral nervous system; gynecologic diseases; antibiotics, antigens, and anthelmintic; and antitumor, as well as other metabolite medicines. The company offers i... [Read more]

Industry Pharmaceutical Preparations
Founded 1964
Employees 250
Stock Exchange KOSDAQ
Ticker Symbol 034940
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.